View in EDS

A Pilot Randomized Controlled Trial of Eye Movement Desensitization and Reprocessing Therapy for Adults With Binge‐Eating Disorder.

Saved in:
Bibliographic Details
Title: A Pilot Randomized Controlled Trial of Eye Movement Desensitization and Reprocessing Therapy for Adults With Binge‐Eating Disorder.
Authors: Hatoum, Amaani H. (AUTHOR), Richard, Katie (AUTHOR), Burton, Amy L. (AUTHOR), Rieger, Elizabeth (AUTHOR), Touyz, Stephen (AUTHOR), Abbott, Maree J. (AUTHOR)
Source: International Journal of Eating Disorders. May2026, Vol. 59 Issue 5, p1009-1022. 14p.
Subjects: Repeated measures design, Statistical power analysis, Medical protocols, T-test (Statistics), Data analysis, Health attitudes, Research funding, Binge-eating disorder, Statistical sampling, Pilot projects, Blind experiment, Multiple regression analysis, Questionnaires, Treatment effectiveness, Randomized controlled trials, Descriptive statistics, Chi-squared test, Longitudinal method, Analysis of variance, Statistics, Comparative studies, Data analysis software, EMDR (Eye-movement desensitization & reprocessing), Psychosocial factors, Adults
Geographic Terms: Australia
Abstract: Objective: Binge‐eating disorder (BED) is a serious psychological condition, often associated with trauma, as well as many critical physical and psychological consequences. Despite the availability of several evidence‐based treatments, full remission rates and long‐term recovery rates remain suboptimal. Eye movement desensitization and reprocessing (EMDR) therapy has demonstrated early promise in the treatment of eating disorders (EDs) but has yet to be examined in those with BED. To our knowledge, the current study was the first pilot randomized controlled trial to examine the feasibility and preliminary efficacy of EMDR therapy in the treatment of core BED symptomatology. Method: The clinical trial protocol was prospectively registered with the Australian New Zealand Clinical Trials Registry (ANZCTR Registration Number: ACTRN12614000894695, 05/08/2014). A two‐arm (EMDR vs. waitlist control), single‐blind, pilot RCT was utilized to examine the feasibility and preliminary efficacy of this approach. Eligible participants (N = 38) were fluent English‐speaking Australian adults (18+ years) who met the diagnostic criteria for BED. An existing EMDR treatment protocol for bulimia nervosa (BN) was adapted for BED (10 sessions). Outcomes were examined before and immediately after treatment completion. Results: A treatment completion rate of 68.8% supported the feasibility of the treatment protocol. Intention‐to‐treat (ITT) analyses demonstrated largely positive effects in favor of the intervention, including significantly larger reductions in binge eating (symptoms, days, and frequency), meta‐cognitive beliefs about eating, eating and shape concerns, anxiety, and sleep disturbance. However, there was no significant benefit of the intervention over control for dietary restraint, weight concerns, self‐esteem, or sexual problems. There were mixed findings for depressive symptoms and dissociative symptoms between the ITT sample and treatment‐completers. Discussion: This pilot RCT supports the feasibility of applying this protocol to a larger‐scale, well‐powered effectiveness trial. It also addresses a critical gap in the literature by being one of the first to examine the potential efficacy of EMDR therapy for adults with BED, and thus contributes foundational preliminary data in support of an additional model of care for those with BED. Summary: This pilot randomized controlled trial was the first to examine the feasibility and preliminary efficacy of eye movement desensitization and reprocessing (EMDR) therapy for core BED symptomatology in adults.A two‐arm (EMDR vs. waitlist control) RCT enrolled 38 English‐speaking Australian adults meeting BED diagnostic criteria.The 10‐session adapted EMDR protocol was found to be feasible, with comparable retention rates to that of 10‐session CBT, and slightly lower retention than pooled estimates from BED treatment trials more broadly.Findings show preliminary benefits, such as reduced binge eating behaviors and related disordered eating cognitions, supporting the need for larger, well‐powered trials to determine their potential as an effective treatment option. [ABSTRACT FROM AUTHOR]
Copyright of International Journal of Eating Disorders is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
Description
Abstract:Objective: Binge‐eating disorder (BED) is a serious psychological condition, often associated with trauma, as well as many critical physical and psychological consequences. Despite the availability of several evidence‐based treatments, full remission rates and long‐term recovery rates remain suboptimal. Eye movement desensitization and reprocessing (EMDR) therapy has demonstrated early promise in the treatment of eating disorders (EDs) but has yet to be examined in those with BED. To our knowledge, the current study was the first pilot randomized controlled trial to examine the feasibility and preliminary efficacy of EMDR therapy in the treatment of core BED symptomatology. Method: The clinical trial protocol was prospectively registered with the Australian New Zealand Clinical Trials Registry (ANZCTR Registration Number: ACTRN12614000894695, 05/08/2014). A two‐arm (EMDR vs. waitlist control), single‐blind, pilot RCT was utilized to examine the feasibility and preliminary efficacy of this approach. Eligible participants (N = 38) were fluent English‐speaking Australian adults (18+ years) who met the diagnostic criteria for BED. An existing EMDR treatment protocol for bulimia nervosa (BN) was adapted for BED (10 sessions). Outcomes were examined before and immediately after treatment completion. Results: A treatment completion rate of 68.8% supported the feasibility of the treatment protocol. Intention‐to‐treat (ITT) analyses demonstrated largely positive effects in favor of the intervention, including significantly larger reductions in binge eating (symptoms, days, and frequency), meta‐cognitive beliefs about eating, eating and shape concerns, anxiety, and sleep disturbance. However, there was no significant benefit of the intervention over control for dietary restraint, weight concerns, self‐esteem, or sexual problems. There were mixed findings for depressive symptoms and dissociative symptoms between the ITT sample and treatment‐completers. Discussion: This pilot RCT supports the feasibility of applying this protocol to a larger‐scale, well‐powered effectiveness trial. It also addresses a critical gap in the literature by being one of the first to examine the potential efficacy of EMDR therapy for adults with BED, and thus contributes foundational preliminary data in support of an additional model of care for those with BED. Summary: This pilot randomized controlled trial was the first to examine the feasibility and preliminary efficacy of eye movement desensitization and reprocessing (EMDR) therapy for core BED symptomatology in adults.A two‐arm (EMDR vs. waitlist control) RCT enrolled 38 English‐speaking Australian adults meeting BED diagnostic criteria.The 10‐session adapted EMDR protocol was found to be feasible, with comparable retention rates to that of 10‐session CBT, and slightly lower retention than pooled estimates from BED treatment trials more broadly.Findings show preliminary benefits, such as reduced binge eating behaviors and related disordered eating cognitions, supporting the need for larger, well‐powered trials to determine their potential as an effective treatment option. [ABSTRACT FROM AUTHOR]
ISSN:02763478
DOI:10.1002/eat.70056